LNDC

Landec Corporation [LNDC] Stock Forecast

Q: What is Landec Corporation stock symbol ?

Landec Corporation is a US stock, located in Santa clara of California and trading under the symbol LNDC

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

LNDC Stock Summary

Has a high level of debt. Debt-to-Equity ratio of 3.71 is considered high.

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 quarters (Quarter statements)

Profit margins (-0.42%) are lower than the previous year (-0.25%)

LNDC has less than 1 year of cash runway

An RSI reading of 30 or below indicates an oversold or undervalued condition.

In the News

LNDC Financial details

Company Rating

Buy

Market Cap

263.63M

Income

Revenue

Book val./share

1.13

Cash/share

0.1

Dividend

Dividend %

Employees

689

Optionable

Shortable

Yes

Earnings

03 Apr 2023

P/E

-3.51

Forward P/E

PEG

P/S

1.47

P/B

7.76

P/C

87.6

P/FCF

-6.29

Quick Ratio

0.94

Current Ratio

2.35

Debt / Equity

3.71

LT Debt / Equity

3.67

EPS (TTM)

EPS next Y

EPS next Q

EPS this Y

41.44%

EPS next Y

EPS next 5Y

EPS last 5Y

NAN%

Revenue last 5Y

-18.74%

Revenue Q/Q

EPS Q/Q

SMA20

-75%

SMA50

SMA100

Inst Own

64.47%

Inst Trans

0.86%

ROA

-32%

ROE

-97%

ROC

-0.53%

Gross Margin

17%

Oper. Margin

-59%

Profit Margin

-42%

Payout

Shs Outstand

Shs Float

Target Price

52W Range

7.65-12.0389

52W High

-27%

52W Low

+25.14%

RSI

Rel Volume

0.81

Avg Volume

64.98K

Volume

52.47K

Perf Week

Perf Month

23.38%

Perf Quarter

Perf Half Y

Beta

1.10229

Volatility

3.07%, 3.45%

Prev Close

Price

8.76

Change

LNDC Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-05-29

Metric	2018-05-27	2019-05-26	2020-05-31	2021-05-30	2022-05-29
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	18.78	19.16	20.2	18.55	6.31
Net income per share	0.92	0.07	-1.31	-1.11	-1.57
Operating cash flow per share	0.71	0.55	-0.58	0.51	-0.83
Free cash flow per share	-0.49	-0.99	-1.5	-0.3	-1.78
Cash per share	0.1	0.04	0.01	0.04	0.06
Book value per share	9.05	9.28	7.91	6.91	3.66
Tangible book value per share	6.31	5.09	4.23	3.32	2.66
Share holders equity per share	9.05	9.28	7.91	6.91	3.66
Interest debt per share	2.68	5.42	7.89	8.07	5.79
Market cap	392.21M	274.15M	316.79M	351.11M	290.83M
Enterprise value	462.25M	425.59M	537.55M	571.22M	442.37M
P/E ratio	15.22	129.19	-8.29	-10.75	-6.28
Price to sales ratio	0.75	0.49	0.54	0.65	1.57
POCF ratio	19.83	17.11	-18.59	23.38	-11.92
PFCF ratio	-28.4	-9.55	-7.24	-40.12	-5.54
P/B Ratio	1.55	1.01	1.37	1.73	2.69
PTB ratio	1.55	1.01	1.37	1.73	2.69
EV to sales	0.88	0.76	0.91	1.05	2.38
Enterprise value over EBITDA	15.5	19.01	-23.51	-108.7	-6.5
EV to operating cash flow	23.37	26.57	-31.54	38.04	-18.13
EV to free cash flow	-33.47	-14.82	-12.29	-65.27	-8.42
Earnings yield	0.07	0.01	-0.12	-0.09	-0.16
Free cash flow yield	-0.04	-0.1	-0.14	-0.02	-0.18
Debt to equity	0.29	0.56	0.96	1.09	1.42
Debt to assets	0.18	0.29	0.41	0.44	0.52
Net debt to EBITDA	2.35	6.76	-9.65	-41.89	-2.23
Current ratio	1.1	0.97	0.96	1.46	1.56
Interest coverage	6.08	1.37	-4.34	-1.64	-4.95
Income quality	0.79	38.98	0.45	-0.46	0.25
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.02	0.02	0.02	0.02	0.04
Intangibles to total assets	0.19	0.24	0.2	0.21	0.1
Capex to operating cash flow	-1.7	-2.79	1.57	-1.58	1.15
Capex to revenue	-0.06	-0.08	-0.05	-0.04	-0.15
Capex to depreciation	-2.71	-2.94	-1.42	-1.2	-1.57
Stock based compensation to revenue	0.01	0.01	0	0.01	0.01
Graham number	13.71	3.9	15.25	13.16	11.38
ROIC	0.06	0.01	-0.06	-0.04	-0.28
Return on tangible assets	0.08	0.01	-0.09	-0.08	-0.17
Graham Net	-3.33	-5.79	-7.51	-7.21	-3.94
Working capital	8.69M	-4.05M	-7.28M	46.43M	44.48M
Tangible asset value	176.21M	148.16M	123.55M	97.28M	78.51M
Net current asset value	-55.08M	-115.91M	-153.16M	-151.82M	-63.5M
Invested capital	0.29	0.56	0.96	1.09	1.42
Average receivables	50.48M	61.72M	72.89M	73.11M	59.09M
Average payables	30.27M	44.32M	52.81M	49.61M	31.69M
Average inventory	28.55M	42.98M	60.22M	67.99M	68.25M
Days sales outstanding	37.51	45.54	47.12	46.96	94.64
Days payables outstanding	28.38	41.34	36.58	37.53	42.59
Days of inventory on hand	26.05	41.46	46.96	54.96	180.17
Receivables turnover	9.73	8.01	7.75	7.77	3.86
Payables turnover	12.86	8.83	9.98	9.73	8.57
Inventory turnover	14.01	8.8	7.77	6.64	2.03
ROE	0.1	0.01	-0.17	-0.16	-0.43
Capex per share	-1.2	-1.54	-0.91	-0.81	-0.95

Quarterly Fundamentals Overview

Last date of statement is 2023-02-26 for Q3

Metric	2022-02-27	2022-05-29	2022-08-28	2022-11-27	2023-02-26
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	1.8	1.61	1.47	1.31	1.62
Net income per share	-0.24	-1.21	-0.41	-0.42	-0.51
Operating cash flow per share	-0.68	0	-0.05	-0.42	-0.51
Free cash flow per share	-0.87	-0.32	-0.15	-0.42	-0.51
Cash per share	0.06	0.06	0.14	0.23	0.1
Book value per share	4.89	3.66	3.28	2.5	1.13
Tangible book value per share	2.9	2.66	2.29	2.03	1.94
Share holders equity per share	4.89	3.66	3.28	2.5	1.13
Interest debt per share	4.71	5.31	5.43	5.29	4
Market cap	339.63M	291.3M	299.91M	259.59M	265.46M
Enterprise value	472.66M	442.85M	452.73M	413.73M	389.45M
P/E ratio	-11.95	-2.04	-6.21	-5.21	-4.33
Price to sales ratio	6.4	6.12	6.92	6.69	5.39
POCF ratio	-16.87	8.09K	-195.64	-20.85	-17.17
PFCF ratio	-13.24	-30.47	-67.21	-20.85	-17.17
P/B Ratio	2.36	2.7	3.1	3.5	7.76
PTB ratio	2.36	2.7	3.1	3.5	7.76
EV to sales	8.91	9.3	10.44	10.66	7.91
Enterprise value over EBITDA	-86.06	-14.47	-136.65	-52.33	-40.15
EV to operating cash flow	-23.48	12.3K	-295.32	-33.23	-25.19
EV to free cash flow	-18.42	-46.33	-101.46	-33.23	-25.19
Earnings yield	-0.02	-0.12	-0.04	-0.05	-0.06
Free cash flow yield	-0.08	-0.03	-0.01	-0.05	-0.06
Debt to equity	0.94	1.42	1.62	2.17	3.71
Debt to assets	0.41	0.52	0.55	0.58	0.54
Net debt to EBITDA	-24.22	-4.95	-46.13	-19.5	-12.78
Current ratio	1.47	1.56	1.4	0.65	2.35
Interest coverage	-2.2	-9.77	-2.26	3.95	7.92
Income quality	1.57	0	0.13	1	1
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0.04	0.04	0.05	0.05	0.04
Intangibles to total assets	0.18	0.1	0.1	0.05	0.06
Capex to operating cash flow	0.27	-266.53	1.91	0	0
Capex to revenue	-0.1	-0.2	-0.07	0	0
Capex to depreciation	-1.57	-2.83	-0.58	0	0
Stock based compensation to revenue	0.01	0.01	0.02	0	0
Graham number	5.15	9.99	5.48	4.86	3.58
ROIC	-0.03	-0.12	-0.03	-0.07	-0.26
Return on tangible assets	-0.03	-0.13	-0.05	-0.05	-0.07
Graham Net	-3.58	-3.93	-4.12	-4.47	-3.69
Working capital	41.97M	44.48M	33.5M	-68.6M	50.77M
Tangible asset value	85.58M	78.51M	67.74M	60.29M	58.84M
Net current asset value	-49.47M	-63.5M	-72.3M	-77.81M	-75M
Invested capital	0.94	1.42	1.62	2.17	3.71
Average receivables	57.42M	48.87M	44.55M	38.31M	34.03M
Average payables	39.56M	17.91M	16.08M	22.17M	21.37M
Average inventory	76.57M	70.27M	65.57M	70.9M	63.11M
Days sales outstanding	84.04	91.03	84.97	82.78	59.19
Days payables outstanding	45.98	39.18	39.24	79.43	30.72
Days of inventory on hand	169.3	165.72	154.14	220.14	101.35
Receivables turnover	1.07	0.99	1.06	1.09	1.52
Payables turnover	1.96	2.3	2.29	1.13	2.93
Inventory turnover	0.53	0.54	0.58	0.41	0.89
ROE	-0.05	-0.33	-0.12	-0.17	-0.45
Capex per share	-0.19	-0.33	-0.1	0	0

LNDC Frequently Asked Questions

What is Landec Corporation stock symbol ?

Landec Corporation is a US stock , located in Santa clara of California and trading under the symbol LNDC

What is Landec Corporation stock quote today ?

Landec Corporation stock price is $8.76 today.

Is Landec Corporation stock public?

Yes, Landec Corporation is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Check Those

Similar Market Cap

Company Profile

Volume Average 64.98K
Market Capitalization 263.63M
Employee 689
CEO Dr. Albert Bolles
Headquarters Santa Clara,CALIFORNIA,US
IPO Date 1996-02-16
Website https://www.landec.com

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California.